Indeed, radiotherapy with clinically relevant single doses reportedly stimulates the proliferation of APCs within tumor-draining lymph nodes (TDLNs), where antigen presentation and activation of CD8+ T cells occur. The gene discussed is CD8A; the disease is neoplasm.